Digital Therapeutics next wave in managing chronic medical conditions – ET HealthWorld

Digital Therapeutics next wave in managing chronic medical conditions – ET HealthWorld

By Aditya Kaicker In the realm of healthcare, technology has emerged as a powerful catalyst for positive change. One area where this transformation is particularly evident is in the reversal of diabetes, specifically type 2 diabetes. Health technology, encompassing innovative tools and applications, is paving the way for effective diabetes management and remission. Moreover, these … Read more

Lupin Digital Health releases results of its digital therapeutics study with ACS patients – ET HealthWorld

Lupin Digital Health releases results of its digital therapeutics study with ACS patients – ET HealthWorld

Chennai: Showing the efficacy of digital therapeutics (DTx) among patients with acute coronary syndrome (ACS) and post-percutaneous coronary interventions, Lupin Digital Health (LDH), a DTx platform, has released the results of a study in India. The one-year-long study was aimed at evaluating the efficacy of LDH’s digital therapeutics platform, Lyfe, on cardiovascular events, rehospitalisation, medication … Read more

With digital therapeutics, you can design your health, Health News, ET HealthWorld

With digital therapeutics, you can design your health, Health News, ET HealthWorld

By Hans Lewis Mumbai: Digital Health has emerged as a go-to-by thing during the last decade thanks to smart phones, mobile applications, wearable devices, cloud-based data platforms, social media platforms, and the like. The result is, that unlike the past, today’s patients enjoy greater power which in other words means they now have the freedom … Read more

Digital Therapeutics is here to stay: Using your smartphone to transform chronic disease management – ET HealthWorld

Digital Therapeutics is here to stay: Using your smartphone to transform chronic disease management – ET HealthWorld

By Dr Suhas Patil Chronic diseases such as hypertension and diabetes are also called lifestyle diseases. Therefore, the treatment of these diseases would seem to be as simple as improving your lifestyle by changing your behaviour, wouldn’t it? But as we all can agree, knowing is not the same as doing. When it comes to … Read more

‘Digital therapeutics have proven to help in reversal of diabetes’ – ET HealthWorld

‘Digital therapeutics have proven to help in reversal of diabetes’ – ET HealthWorld

In an interaction with ETHealthworld’s Rashmi Mabiyan, Dr Arbinder Singal, Co-Founder, and CEO, Fitterfly, elucidates the growth of digital therapeutics in the management of diabetes and the new initiatives being launched by the company. Do you see the management of diabetes through digital therapeutics picking up in India?As per statistics, the digital therapeutics market is … Read more

Evusheld for COVID: Lifesaving and Free, but Still Few Takers

Evusheld for COVID: Lifesaving and Free, but Still Few Takers

Aug. 1, 2022 – Evusheld, the medication used to prevent COVID-19 infection in patients at high risk, has issues. Namely, supplies of the potentially lifesaving drug outweigh demand. At least 7 million people who are immunocompromised could benefit from it, as could many others who are having cancer treatment, have had a transplant, or are … Read more

Digital Therapeutics: Revolutionizing the virtual healthcare industry – ET HealthWorld

Digital Therapeutics: Revolutionizing the virtual healthcare industry – ET HealthWorld

by Rohan VermaConstant innovation and technological advancement across healthcare applications from use of AI, ML to health monitoring have been helping stakeholders of the industry address the vast data pool while providing them with valuable insights. Individuals with chronic health conditions have always required a regular interaction with doctors/health care providers & healthcare systems. Patients … Read more

WHO Says No to Remdesivir as COVID-19 Treatment

WHO Says No to Remdesivir as COVID-19 Treatment

By Robert Preidt HealthDay Reporter FRIDAY, Nov. 20, 2020 (HealthDay News) — The antiviral drug remdesivir is not recommended for hospitalized COVID-19 patients because there’s no evidence that it reduces their need for ventilation or improves their chances of survival, a World Health Organization panel said Thursday. Remdesivir is regarded as a potential … Read more